All 65 HELX (FRANKLIN GENOMIC ADVANCEMENTS ETF) Holdings
There are 65 HELX holdings. Top 10 companies weight: 47.44%.
Total Market Cap: $2.34T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (65 stocks) | +19.26% | 35.14 | 24.65 | 0.30 | +16.06% | +20.99% | 0.77 | ||||||||||
51 | KNSA | N/A | 0.33% | $62.58 | $4.72B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 68.37 | 58.14 | N/A | N/A | N/A | 78 | +8.85% | $68 | +34.65% | 0.54 |
52 | TARS | N/A | 0.26% | $56.25 | $2.47B | Biotechnology | Healthcare | N/A | N/A | 106.38 | N/A | N/A | N/A | 77 | +68.11% | $95 | +16.34% | 0.61 |
53 | BIO | Bio-rad Laboratories Inc Class A | 0.25% | $301.95 | $7.97B | Medical Devices | Healthcare | N/A | N/A | 34.36 | 1.19 | N/A | N/A | 60 | -1.64% | $297 | -14.56% | 0.89 |
54 | NGNE | Neurogene Inc | 0.24% | $37.34 | $616M | Biotechnology | Healthcare | +11.24% | N/A | N/A | N/A | N/A | N/A | 75 | +118.83% | $82 | -26.10% | 1.88 |
55 | BMY | Bristol-myers Squibb Co | 0.24% | $60.18 | $120B | Drug Manufacturers - General | Healthcare | +5.08% | 13.82 | 9.59 | 1.54 | N/A | N/A | N/A | N/A | N/A | +1.92% | N/A |
56 | LQDA | Liquidia Corp Ordinary Shares | 0.24% | $77.08 | $6.87B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 323.20 | 20.12 | N/A | N/A | N/A | 75 | -3.67% | $74 | +97.89% | 1.11 |
57 | ONC | Beone Medicines Ltd Adr | 0.23% | $310.58 | $36B | Biotechnology | Healthcare | N/A | 69.54 | 47.39 | N/A | N/A | N/A | 81 | +33.57% | $415 | +0.26% | 0.54 |
58 | TGTX | Tg Therapeutics Inc | 0.23% | $53.96 | $8.64B | Biotechnology | Healthcare | N/A | 18.97 | 58.48 | 0.02 | N/A | N/A | 66 | +8.19% | $58 | +7.20% | 0.80 |
59 | TRAX | First Tracks Biotherapeutics Inc | 0.19% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
60 | WGS | N/A | 0.14% | $60.65 | $1.96B | Diagnostics & Research | Healthcare | N/A | N/A | 204.08 | N/A | N/A | N/A | 77 | +34.84% | $82 | -31.83% | 1.65 |
61 | WVE | Wave Life Sciences Ltd | 0.10% | $5.73 | $1.14B | Biotechnology | Healthcare | -19.81% | N/A | N/A | N/A | N/A | N/A | 78 | +282.90% | $22 | -3.51% | 1.46 |
62 | RXRX | Recursion Pharmaceuticals Inc Class A | 0.07% | $2.89 | $1.76B | Biotechnology | Healthcare | -10.03% | N/A | N/A | N/A | N/A | N/A | 65 | +150.87% | $7.25 | -39.61% | 2.62 |
63 | n/a | Euro | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
64 | n/a | Danish Krone | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
65 | n/a | Omniab | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
HELX (FRANKLIN GENOMIC ADVANCEMENTS ETF) Sector Allocation
HEALTHCARE
88.30%MATERIALS
2.20%INFORMATION TECHNOLOGY
0.90%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%